Biol Reprod Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jablonka-Shariff, A.
Right arrow Articles by Olson, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jablonka-Shariff, A.
Right arrow Articles by Olson, L. M.
Agricola
Right arrow Articles by Jablonka-Shariff, A.
Right arrow Articles by Olson, L. M.
Biology of Reproduction 61, 171-177 (1999)
©Copyright 1999 Society for the Study of Reproduction, Inc.


Articles

Abnormal Estrous Cyclicity after Disruption of Endothelial and Inducible Nitric Oxide Synthase in Mice

Albina Jablonka-Shariffa, Sapna Ravia, Angeline N. Beltsos2,a, Laura L. Murphyb, and Lisa M. Olson1,a

a Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, Missouri 63110 b Department of Physiology, Southern Illinois University at Carbondale School of Medicine, Carbondale, Illinois 62901


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIAL AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The roles of nitric oxide (NO) and nitric oxide synthase (NOS) in reproduction were studied by examining the estrous cycle of wild-type (WT) mice, inducible NOS (iNOS)-, and endothelial NOS (eNOS)-knockout mice. We observed an average estrous cycle of 4.8 ± 0.2 days in WT mice. While we observed no significant influence of iNOS deficiency on cycle length, eNOS-knockout females showed a significantly longer estrous cycle (6.6 ± 0.6 days; p < 0.03) than WT females, due to an extension of diestrus (p < 0.03). There was no influence of iNOS deficiency on ovulation rate compared with that in WT females; however, eNOS-knockout mice showed a significant reduction (p < 0.05) in ovulatory efficiency relative to WT or iNOS-knockout females. In contrast to WT females, in which the highest level of estradiol (E2) was observed at 1500 h of proestrus, iNOS-knockout females reached a peak of E2 at 1830 h of proestrus. In eNOS-knockout females, the peak of E2 occurred at 1830 h, as in iNOS-knockout mice; however, E2 levels were 5-fold and 3-fold higher (p < 0.05) than levels observed in WT and iNOS-knockout females, respectively. There was no effect of genotype on the plasma LH concentrations at proestrus. On the first day of diestrus, eNOS-knockout females showed significantly higher plasma E2 and progesterone levels (p < 0.05) relative to WT and iNOS-knockout females. The dysfunction in cyclicity, ovulation rate, ovarian morphology, and steroidogenesis in eNOS-knockout female mice strongly supports the concept that eNOS/NO plays critical roles in ovulation and follicular development.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIAL AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Nitric oxide (NO), a highly reactive free radical molecule, has recently been implicated in events associated with a variety of female reproductive functions. Specifically, roles for NO in ovulation [16], estradiol (E2) synthesis [79], follicle survival [10], and oocyte meiotic maturation [6] have been demonstrated.

NO is synthesized from L-arginine by nitric oxide synthase (NOS) isozymes, yielding NO and L-citrulline [11]. To date, three genes encoding NOSs with different biochemical characteristics have been isolated [12, 13]. Two constitutively expressed isoforms were first identified in the endothelium (eNOS) and brain [11, 12]. An inducible isoform (iNOS) has been found in many cells and is correlated with cytostatic and cytotoxic events [13].

Studies in our laboratory and others have demonstrated that eNOS and iNOS are expressed in a cell- and development-specific manner in the superovulated rodent ovary [4, 14]. Furthermore, both isoforms were regulated by gonadotropins [14]. Ovarian eNOS and iNOS also have been detected during the estrous cycle in rats [15, 16]. NO is synthesized by rat [2, 10] and human [7, 17] ovarian cells, and treatment of rats with pharmacological NOS inhibitors lowered the number of ovulated oocytes both in perfused ovaries and in vivo [1, 3, 5, 18].

The importance of independent roles of iNOS and eNOS in female reproduction has been studied in our laboratory using mice deficient in iNOS (iNOS-knockout) or eNOS (eNOS-knockout). Both iNOS-knockout and eNOS-knockout female mice showed a significant reduction in ovulation rate relative to wild-type (WT) controls [6, 19]. In normal breeding we have observed a lower pregnancy rate in eNOS-knockout females compared with either WT or iNOS-knockout females. Furthermore, among those mice that become pregnant, the number of pups born per litter was fewer, and these pups had a high initial mortality rate [6].

The objective of the present study was to examine the influence of genotype on several aspects of the normal reproductive capacity, namely, cyclicity, ovulation rate, steroidogenesis, and gonadotropin levels during the estrous cycle in WT, iNOS-, and eNOS-deficient mice.


    MATERIAL AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIAL AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Mice

Wild-type (129Sv/Ev) females were originally obtained from Taconic Laboratories (Germantown, NY). Inducible NOS-knockout mice on a 129Sv/Ev/C57BL6 genetic background were originally obtained from Dr. John Mudgett, Merck Research Laboratories, Rahway, NJ [20], and their offspring were bred as homozygote matings (iNOS-/-). Endothelial NOS-knockout mice on a 129Sv/Ev/C57BL6 genetic background were originally obtained from Drs. Paul Huang and Mark Fishman, Harvard Medical School, Boston, MA [21], and their offspring were bred either as homozygote matings (eNOS-/-) or heterozygote females (eNOS+/-) with eNOS-knockout males [6]. Pups were weaned at 21 days of age, at which time all pups were sexed. Pups from heterozygote matings were ear notched for identification purposes, and a 1-cm segment of the tail was removed and prepared for isolation of genomic DNA. The genotype of the offspring was determined by Southern blot analysis [6]. Mice were maintained in a barrier facility with a 12L:12D cycle (lights-on from 0600 h to 1800 h) so that midnight (2400 h) was the midpoint of the dark cycle. Temperature was maintained at 25°C, and mice were provided food and water ad libitum.

The animal protocol used was approved by the Washington University Medical School institutional committee on laboratory animal care and was conducted in accordance with the NIH guide for the care and use of laboratory animals.

Classification of the Estrous Cycle and Tissue Collection

To examine the influence of genotype on the length of the estrous cycle, vaginal smears from WT, iNOS-knockout, and eNOS-knockout female mice at 13–16 wk of age were monitored daily between 1400 h and 1500 h. The mouse's tail was raised and a cotton swab, prepared from tooth picks and sterile cotton, was inserted into the vagina and rotated. When the swab was removed, it was rolled onto a microscope slide. The smears were classified into one of four phases of estrus: a thin smear of leukocytes and elongated nucleated epithelium indicated proestrus; large cornified epithelial cells were exclusively found in estrus; metestrus was marked by a thick smear composed of equal numbers of nucleated epithelial cells and leukocytes; and a smear consisting almost exclusively of leukocytes depicted diestrus [22, 23]. Each cycle length was determined as the length of time between two consecutive occurrences of estrus. After the mice had progressed through at least three consecutive estrous cycles, the length of the estrous cycle and the number of days spent at each stage of the cycle were evaluated.

To determine whether iNOS and eNOS deficiency affected ovarian weight, ovarian morphology, and hormone concentrations, mice were weighed and killed at 1500 h and 1830 h on proestrus and at 1500 h on the first day of diestrus. Blood samples were collected by cardiac puncture, and plasma from these samples was stored at -20°C. Given the limitations of the small amount of plasma obtained from a limited number of mice, we chose to examine the levels of E2 and LH at proestrus, and E2 and progesterone (P4) at diestrus of the estrous cycle. Visual examination of uteri provided additional confirmation of the phase of the estrous cycle. Animals in late proestrus had large uteri with a substantial amount of intraluminal fluid. Mice in estrus had smaller uteri and a small amount of intraluminal fluid. In turn, small uteri without intraluminal fluid were characteristic of mice in diestrus [16]. All animals were killed by CO2 asphyxiation, followed by cervical dislocation.

Ovulation Efficiency

To determine the number of ovulated oocytes during the estrous cycle, WT, iNOS-knockout, and eNOS-knockout females (n = 4 mice per genotype) were killed at 0800 h in the morning of estrus. For each mouse, the enlarged and translucent ampulla of each oviduct was excised and trimmed, and the ovulated oocyte-cumulus complexes were recovered into a Petri dish with Dulbecco's PBS (Sigma Chemical Co., St. Louis, MO). Oocytes were counted and data are expressed as the mean number of ovulated oocytes per mouse per genotype [6].

Hormone Assays

E2 and P4 concentrations were determined in plasma using commercial RIA kits (Abbott Laboratories, Abbott Park, IL, for E2; Diagnostic Products Corp., Los Angeles, CA, for P4). Samples were analyzed singly or in duplicate when sufficient plasma was available. The inter- and intraassay coefficients of variation were 4.5% and 4.1% for E2, and 5.1% and 2.6% for P4, respectively. Plasma LH concentration was determined in a double-antibody RIA using established procedures [24]. Hormone standards and reagents were supplied by the National Hormone and Pituitary Program (Bethesda, MD). Goat anti-rabbit {gamma}-globulin (Calbiochem, La Jolla, CA) was used as second antibody. LH results were expressed in term of the NIADDK-rat reference preparation RP-3 (Rockville, MD). The sensitivity of the LH assay was 0.2 ng/ml and the intraassay coefficient of variation was 6.8%.

Ovarian Histology

To determine whether lack of NO synthesis influences ovarian development, ovaries collected on proestrus and diestrus of the estrous cycle (n = 4 mice per genotype) were examined. Both ovaries were removed, cleaned of extraneous tissue, weighed, and fixed in Bouin's solution [25]. After 20-h fixation, the tissue was dehydrated in a graded ethanol series and embedded in paraffin wax. Serial sections (6 µm thick) of ovaries (4 ovaries per stage of the cycle per genotype) were stained with hematoxylin and eosin [22]. For each ovary (average 200 sections per ovary), every fifth section was examined to obtain an overall view of the follicular populations at proestrus and diestrus of the estrous cycle in WT, iNOS-knockout, and eNOS-knockout mice. Sexually mature females contain a heterogenous population of follicles at different developmental stages [26, 27]; therefore, the specific analysis was limited to large antral preovulatory follicles in proestrous mice and small antral follicles and corpora lutea (CL) in diestrous mice. At least two sets of CL are present in diestrous ovaries. The most recent CL (newly formed) stain blue with hematoxylin; the latter (older) are stained more heavily with eosin [22, 28].

Statistical Analysis

All data are presented as the mean ± SEM. Data on the length of the estrous cycle, hormone concentrations, and ovulation efficiency were analyzed using ANOVA, and multiple comparisons were made with Bonferroni's t-test. Number of days spent in each stage of the estrus cycle was analyzed via the chi-square test [29].


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIAL AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Estrous Cycle of iNOS-Knockout and eNOS-Knockout Females

To determine whether iNOS-knockout and eNOS-knockout females were undergoing normal estrous cycling, vaginal smears were taken daily, examined histologically, and compared with those of WT females. Control WT females reached estrus every 4 to 5 days (Fig. 1), and their smear patterns at each stage displayed a characteristic morphology. The length of the estrous cycle was not significantly altered (p = 0.06) in iNOS-knockout mice compared with control WT mice (Fig. 1). However, we consistently observed a longer diestrus in iNOS-knockout mice compared with WT mice, indicating a moderate alteration in cyclicity. In contrast, eNOS-knockout females showed significantly lengthened estrous cycles, reaching estrus every 6.6 ± 0.6 days, relative to the cycles of control WT females (p < 0.03) (Fig. 1). The estrous cycle of eNOS-knockout females included a significantly extended diestrus (p < 0.03), whereas the duration of all other stages was not significantly changed compared to those of WT mice (Fig. 2).



View larger version (42K):
[in this window]
[in a new window]
 
FIG. 1. Length of the estrous cycle in WT (n = 19), iNOS-knockout (iNOS-KO; n = 15), and eNOS-knockout (eNOS-KO; n = 10) mature female mice. Mean cycle length was determined as the length of time between 2 consecutive occurrences of estrus, and only females undergoing at least 3 consecutive cycles were included in the data. Data are the mean ± SEM. Values with different letters indicate significant differences between genotypes (p < 0.03).



View larger version (49K):
[in this window]
[in a new window]
 
FIG. 2. Number of days spent at proestrus, estrus, metestrus, and diestrus of the estrous cycle for WT (n = 19), iNOS-knockout (iNOS-KO; n = 15), and eNOS-knockout (eNOS-KO; n = 10) females. Data are the mean ± SEM. *Significantly different from both WT and iNOS-KO females (p < 0.03).

Effects of iNOS and eNOS Deficiency on Ovarian Weight and Steroidogenesis

We observed no effect of genotype on body weight (overall mean for WT, iNOS-knockout, and eNOS-knockout females = 24.0 ± 0.5 g) and ovarian weight (overall mean = 5.4 ± 0.2 mg) during the estrous cycle (Table 1). Furthermore, there was no influence of iNOS or eNOS deficiency on the ratio of ovarian weight to body weight compared with that for control WT females (Table 1).


View this table:
[in this window]
[in a new window]
 
TABLE 1. Body and ovarian weights of wild-type, iNOS-knockout, and eNOS-knockout mice during the estrous cycle (mean ± SEM).

Plasma concentrations of E2, LH, and P4 in WT, iNOS-knockout, and eNOS-knockout females are shown in Table 2. In WT females, the highest level of plasma E2 was observed at 1500 h on the afternoon of proestrus. By 1830 h that same day, E2 had declined significantly (p < 0.001) and remained low at diestrus (Table 2). Inducible NOS-knockout females also showed cyclic changes in plasma E2 levels, but the pattern was different from that in WT females (Table 2). At 1500 h on proestrus, the level of E2 was significantly lower than observed in WT females. The E2 level then increased and reached a peak at 1830 h of proestrus followed by a decline at diestrus (p < 0.05). In eNOS-knockout females the preovulatory peak of E2 occurred at 1830 h of proestrus, similar to the time in iNOS-knockout mice; however, the concentration of E2 was 5-fold and 3-fold higher (p < 0.05) than the levels observed in WT and iNOS-knockout mice, respectively (Table 2). The E2 level of eNOS-knockout mice decreased at diestrus but remained higher (2-fold; p < 0.05) than the E2 concentrations for WT and iNOS-knockout mice.


View this table:
[in this window]
[in a new window]
 
TABLE 2. Plasma E2, LH, and P4 concentrations in wild-type, iNOS-knockout, and eNOS-knockout mice during the proestrus and diestrus of the estrous cycle (mean ± SEM).*

We observed no effect of genotype on the plasma LH level at 1500 h of proestrus (Table 2). There was a significant rise in LH concentration at 1830 h of proestrus for WT (14-fold, p < 0.05) and eNOS-knockout (3-fold; p < 0.05) mice, but no significant difference between genotypes. A 2-fold increase in LH levels at 1830 h of proestrus in iNOS-knockout females did not achieve significance (p = 0.06) (Table 2).

There was no difference in plasma P4 levels between WT and iNOS-knockout mice on the first day of diestrus. However, eNOS-knockout mice showed a significantly higher (3-fold; p < 0.05) plasma P4 level on the first day of diestrus relative to either control WT or iNOS-knockout females (Table 2).

Ovulation Rate and Ovarian Morphology of WT, iNOS-Knockout, and eNOS-Knockout Mice

There was no influence of iNOS deficiency on ovulation rate compared with that in WT females (7.50 ± 0.86 oocytes per mouse and 8.25 ± 1.03 oocytes per mouse, respectively) (Fig. 3). However, the ovulatory efficiency of eNOS-knockout females was significantly reduced (4.75 ± 1.10 oocytes per mouse) relative to that in control WT or iNOS-knockout females (inhibition of 42% and 36%, respectively; p < 0.05) (Fig. 3).



View larger version (42K):
[in this window]
[in a new window]
 
FIG. 3. Effects of iNOS and eNOS deficiency (iNOS-KO and eNOS-KO, respectively) on ovulation rate during the estrous cycle. Data are the mean ± SEM (n = 4 mice per genotype). Values with different letters indicate significant differences between genotypes (p < 0.05).

To assess the effect of disruption of the iNOS or eNOS gene on ovarian morphology, histological studies were conducted on 4 ovaries at each stage of the cycle for each genotype. The ovaries obtained from sexually mature cycling mice contain a heterologous population of follicles at different stages of development, among which primary and secondary follicles, various sizes of antral follicles, and CL could be observed. Paraffin-embedded sections of ovaries from iNOS-knockout and eNOS-knockout females at proestrus and diestrus of the estrous cycle were compared with those of the WT females (Fig. 4). The characteristic antral preovulatory follicle with its oocyte surrounded by a well-formed cumulus was indicative of late proestrus. The ovary of diestrus was marked by an abundance of healthy primary and secondary follicles. The number of large antral follicles in iNOS-knockout mice was not different from that in the WT mice (4.3 ± 1.2 vs. 4.7 ± 0.3 per ovary) (Fig. 4, A and C, respectively). Ovaries from eNOS-knockout females collected during proestrus contained fewer large antral follicles (2.3 ± 0.5 per ovary; p < 0.05) compared with ovaries from WT or iNOS-knockout mice (Fig. 4E). Similar to the findings for proestrous ovaries, no morphological differences were noted between diestrous ovaries collected from WT and iNOS-knockout mice (Fig. 4, B and D, respectively). Small antral follicles and newly formed CL stained blue with hematoxylin, as well as older red-stained (with eosin) CL, were observed in ovaries from both WT and iNOS-knockout females (Fig. 4, B and D, respectively). Ovaries from eNOS-knockout mice during diestrus showed fewer newly formed CL, whose number was comparable to the number of ovulated oocytes. Some ovaries from eNOS-knockout females also contained luteinized follicles and many growing antral follicles undergoing atresia (Fig. 4F).



View larger version (109K):
[in this window]
[in a new window]
 
FIG. 4. Representative light photomicrographs of ovarian sections from WT, iNOS-knockout, and eNOS-knockout female mice collected at proestrus (1500 h; A, C, and E, respectively) or at diestrus (1500 h; B, D, and F, respectively) of the estrous cycle (n = 4 ovaries per stage of the cycle per genotype), stained with hematoxylin and eosin. Long arrows indicate large antral preovulatory follicles (A, C, E); small arrows show small antral follicles and CL (B, D, F). x40.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIAL AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The objective of this study was to examine the unique roles of iNOS- and eNOS-derived NO in the regulation of the estrous cycle in mice. We used mice in which the gene for iNOS and eNOS had been disrupted through homologous recombination [21, 30] and studied the cyclicity, ovulation rate, ovarian morphology, and steroidogenesis of adult cycling females. We observed that eNOS-deficient females exhibited prolonged diestrus and an extended estrous cycle (6–7 days) compared with WT or iNOS-knockout females, which reached estrus every 4–5 days. The cyclicity data in the present study extend our previous findings of abnormal reproductive performance in eNOS-knockout mice [6]. Recently, we demonstrated that adult cycling eNOS-knockout females had significantly fewer pups born per litter with a higher mortality rate than WT or iNOS-knockout females [6].

In addition to abnormal cyclicity, our studies on ovarian morphology have shown that eNOS deficiency affects follicular development [31]. Ovaries from eNOS-deficient females obtained during proestrus contained a lower number of large antral follicles and fewer CL at diestrus compared with ovaries from WT or iNOS-deficient females. Supporting a role for eNOS-derived NO in follicular development is the positive staining for eNOS in granulosa and thecal cells in the follicles [4, 6, 14] and the oocyte-specific expression of eNOS both within the follicle and after ovulation [6]. Furthermore, recent studies in patients undergoing in vitro fertilization treatment demonstrated that circulating nitrite/nitrate levels increase with follicular development and are correlated with follicular size [17]. Thus, the relationship between the NO pathway and follicular growth could be necessary for both follicular and oocyte development.

There is now compelling evidence that NO also plays a role in the ovulatory process. It has been reported that inhibition of NOS with competitive inhibitors resulted in fewer ovulations both in vivo and with use of perfusion systems in rats and rabbits [1, 3, 14, 18, 32]. A recent study in our laboratory demonstrated that superovulated eNOS-deficient female mice showed a significant reduction in the number of ovulated oocytes relative to WT females [6]. Furthermore, ovulated oocytes obtained from eNOS-knockout females showed abnormalities in meiotic maturation and increased oocyte cell death relative to oocytes obtained from WT females, suggesting possible defects in follicular and oocyte development [6]. In the present study we observed that ovulatory efficiency of eNOS-knockout females was also significantly reduced during the estrous cycle relative to that of WT and iNOS-knockout females. We observed no effect of iNOS deficiency on the ovulation rate during the estrous cycle compared with that in WT females. Although many investigators have suggested a role for iNOS in the ovulatory process, the data are variable. For example, the pattern of ovarian iNOS expression is not consistent between laboratories [4, 7, 14]. Inducible NOS protein was localized exclusively in the thecal cell layers and stroma of preovulatory follicles in rat ovaries, and its level is regulated by gonadotropins, suggesting that iNOS/NO may function as a signal for somatic cells to properly modulate the theca and tunica albuginea of the follicle necessary for the rupture of the follicular wall [4, 14]. However, in contrast to iNOS protein levels, iNOS mRNA was detected only in granulosa cells of secondary preantral follicles with the highest amounts in unstimulated rat ovaries [7]. In another study performed in rats, a significant increase in iNOS gene expression was shown in the early stage of first proestrus, followed by a decline in its transcription in the late stage of proestrus [16]. Interestingly, the same investigators reported that the significant increase in iNOS protein expression in the late stage of first proestrus, just prior to first ovulation, coincided with elevated levels of serum E2 and LH [16]. Due to the variable data in the literature, it is difficult to make firm conclusions concerning the function and regulation of ovarian iNOS during the periovulatory period. Our data, however, support a primary role for eNOS rather than iNOS-derived NO in ovulation.

The extension of the estrous cycle, along with the reduced number of developing follicles and ovulated oocytes in eNOS-knockout mice, suggested potential regulation of the neuroendocrine-ovarian axis by NO and/or local control of ovarian steroidogenesis by NO. In terms of regulation of neuroendocrine function, constitutive NOSs have been localized in several hypothalamic areas [33] and have also been shown in the posterior [34] and anterior pituitary [35]. Recent in vivo and in vitro investigations have demonstrated that NO is involved in the generation of both pulsatile and surge patterns of LH secretion through the regulation of GnRH [3639], and therefore may influence the production of ovarian steroids via this mechanism. Furthermore, because NO is also involved in the control of vascular tone, it may indirectly influence hormone release by regulating hypophyseal portal blood flow. In the present study we observed a 14-fold rise in LH levels at 1830 h compared with 1500 h during proestrus in WT females. In both eNOS-knockout and iNOS-knockout mice, peak LH levels were lower than that observed in WT mice. The LH peak for eNOS-deficient females was only 3-fold higher at 1830 h relative to its level at 1500 h, and was significantly lower compared with that of WT females at 1830 h. While LH levels did rise in iNOS-knockout mice between 1500 h and 1830 h, the change was not statistically significant. The inability to detect a significant change in peak LH levels at 1830 h versus 1500 h in iNOS-knockout mice suggests that the LH peak may have occurred earlier, since we observed no dysfunction in the ovulation rate or level of ovarian steroids of iNOS-knockout females compared with WT females. A close estimate of the LH value and time of the true peak could be determined only by more frequent sampling of plasma in individual iNOS- and eNOS-deficient mice, since the time of LH rise is not entirely synchronous among animals [40, 41]. Furthermore, the maximal serum LH concentration on the afternoon of proestrus in rats varies greatly from animal to animal [41].

An alternative explanation for the dysregulation of the estrous cycle of eNOS-knockout mice may relate to ovarian steroid production. It is now well established that the surge of gonadotropins leading to ovulation is regulated by E2 and P4 [4246]. E2 is the primary trigger for the preovulatory gonadotropin surge, and in rats its serum levels normally fall rapidly on proestrus afternoon during the LH surge [43, 47]. Although E2 is essential for the gonadotropin surge, Turgeon [47] demonstrated that its continued secretion during proestrus in rats is not necessary for the surge and is, in fact, inhibitory to the surge. Thus, abnormal elevations in E2 levels may result in inhibition of the LH surge. Several studies have demonstrated that NO negatively regulates E2 synthesis in human and rat luteal cells by binding to aromatase and directly inhibiting its activity [1, 7, 8, 48]. Therefore, a lack of ovarian NO would result in increased E2 levels. The results obtained in the present study show that plasma E2 levels of eNOS-deficient females at late proestrus and diestrus were significantly higher than those of WT or iNOS-deficient females. We have also observed higher E2 levels in superovulated eNOS-knockout mice compared with WT mice just after ovulation [6]. These data support a role for eNOS-derived NO in the local regulation of E2 synthesis. In addition to increased E2 levels, we observed elevated levels of P4 in eNOS-knockout mice during diestrus. It is well established that plasma P4 drops in the morning of diestrus in mice when regression of the CL of the cycle normally occurs [46]. The extended diestrus in eNOS-deficient mice, in combination with elevated E2 and P4 secretion during diestrus, suggests that eNOS/NO may locally regulate steroidogenesis and modulate the life span of CL.

An extended luteal life span could also be the result of increased plasma prolactin levels. Indeed, transgenic mice and rats overexpressing high levels of human growth hormone (hGH), which binds murine prolactin receptors [49, 50], show significant prolongation of the estrous cycle and elevated P4 levels similarly to eNOS-knockout mice. However, in contrast to the subfertile eNOS-knockout mice, transgenic mice expressing high levels of hGH [49] are fertile and show increased ovulation rate relative to that in control mice. A lack of NO may also result in altered prolactin levels either due to direct regulation of prolactin secretion by NO or via an indirect effect of NO on E2 synthesis. These data suggest that some of the reproductive defects observed in eNOS-knockout mice may be due to abnormal prolactin secretion.

Taken together, the deficiency of eNOS-derived NO in eNOS-knockout females, correlated with dysfunction in cyclicity, ovarian morphology, and alteration in steroidogenesis, strongly supports the concept that eNOS/NO has important roles in ovulation and follicular development. Furthermore, the iNOS- and eNOS-deficient mice provide excellent tools to separate the function for each isoform and to study the roles of iNOS and eNOS in ovarian processes.


    ACKNOWLEDGMENTS
 
The authors thank Janet Willand (Washington University Medical School, St. Louis, MO) for her help with the steroid assays.


    FOOTNOTES
 
1 Correspondence and current address: Lisa M. Olson, NCP-U4B, Monsanto Company, 800 N. Lindbergh Blvd., St. Louis, MO 63167. FAX: 314 694 8215; lisa.maria.olson{at}monsanto.com Back

2 Current address: Loyola University, Stritch School of Medicine, Department of Obstetrics and Gynecology, 2160 S. First Avenue, Maywood, IL 60153. Back

Accepted: February 24, 1999.

Received: September 10, 1998.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIAL AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Bonello N, McKie K, Jasper M, Andrew L, Ross N, Braybon E, Brannstrom M, Norman RJ. Inhibition of nitric oxide: effects of interleukin-1ß-enhanced ovulation rate, steroid hormones, and ovarian leukocyte distribution at ovulation in the rat. Biol Reprod 1996; 54:436–445.[Abstract]
  2. Ellman C, Corbet JA, Misko TP, McDaniel M, Beckerman KP. Nitric oxide mediates interleukin-1ß induced cellular cytotoxicity. A potential role for nitric oxide in the ovulatory process. J Clin Invest 1993; 92:3053–3056.
  3. Shukovski L, Tsafriri A. The involvement of nitric oxide in the ovulatory process in the rat. Endocrinology 1994; 135:2287–2290.[Abstract]
  4. Zackrisson U, Mikuni M, Wallin A, Delbro D, Hedin L, Brannstrom M. Cell-specific localization of nitric oxide synthases (NOS) in the rat ovary during follicular development, ovulation and luteal formation. Hum Reprod 1996; 11:2667–2673.[Abstract/Free Full Text]
  5. Jablonka-Shariff A, Basuray R, Olson LM. Ovarian nitric oxide promotes human chorionic gonadotropin-induced oocyte maturation. In: Program of the 44th annual meeting of the Society for Gynecological Investigation; 1997; San Francisco, CA. Abstract 626.
  6. Jablonka A, Olson LM. The role of nitric oxide in oocyte meiotic maturation and ovulation: meiotic abnormalities of endothelial nitric oxide synthase knock-out mouse oocytes. Endocrinology 1998; 139:2944–2954.[Abstract/Free Full Text]
  7. Van Voorhis BJ, Dunn MS, Snyder GD, Weiner CP. Nitric oxide: an autocrine regulator of human granulosa-luteal cell steroidogenesis. Endocrinology 1994; 135:1799–1806.[Abstract]
  8. Olson LM, Jones-Burton CM, Jablonka-Shariff A. Nitric oxide decreases estradiol synthesis in rat luteal cells in vitro: possible role for nitric oxide in functional luteal regression. Endocrinology 1996; 137:3531–3539.[Abstract]
  9. Masuda M, Kubota T, Kamada S, Aso T. Nitric oxide inhibits steroidogenesis in porcine granulosa cells. In: Program of the 78th annual meeting of the Endocrine Society; 1996; San Francisco, CA. Abstract P2–711.
  10. Chun S-Y, Eisenhauer KM, Kubo M, Hsueh AJW. Interleukin-1ß suppresses apoptosis in rat ovarian follicles by increasing nitric oxide production. Endocrinology 1995; 136:3120–3127.[Abstract]
  11. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43:109–142.[Medline]
  12. Lamas S, Marsden PA, Li GK, Tempst P, Michel T. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci USA 1992; 89:6348–6352.[Abstract/Free Full Text]
  13. Xie Q, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Ding A, Troso T, Nathan C. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992; 256:225–228.[Abstract/Free Full Text]
  14. Jablonka-Shariff A, Olson LM. Hormonal regulation of nitric oxide synthases and their cell-specific expression during follicular development in the rat ovary. Endocrinology 1997; 138:460–468.[Abstract/Free Full Text]
  15. Chatterjee S, Gangula RR, Dong Y-L, Yallampalli C. Immunocytochemical localization of nitric oxide synthase-III in reproductive organs of female rats during the oestrous cycle. Histochem J 1996; 28:715–723.[CrossRef][Medline]
  16. Srivastava V, Jones BJ, Dookwah H, Hiney JK, Dees WL. Ovarian nitric oxide synthase (NOS) gene expression during peripubertal development. Life Sci 1997; 61:1507–1516.[CrossRef][Medline]
  17. Anteby EY, Hurwitz A, Korach O, Revel A, Simon A, Finci-Yeheskel Z, Mayer M, Laufer N. Human follicular nitric oxide pathway: relationship to follicular size, oestradiol concentration and ovarian blood flow. Hum Reprod 1996; 11:1947–1951.[Abstract/Free Full Text]
  18. Yamauchi J, Miyazaki T, Iwasaki S, Kishi I, Kuroshima M, Tei C, Yoshimura Y. Effects of nitric oxide on ovulation and ovarian steroidogenesis and prostaglandin production in the rabbit. Endocrinology 1997; 138:3630–3637.[Abstract/Free Full Text]
  19. Beltsos AN, Jablonka-Shariff A, Olson LM. Inducible nitric oxide synthase: a role in the ovulatory process? In: Program of the 30th annual meeting of the Society for the Study of Reproduction; 1997; Portland, OR. Abstract 135.
  20. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie Q, Sokol K, Hutchinson N, Chen H, Mudgett JS. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 1995; 81:641–650.[CrossRef][Medline]
  21. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995; 377:239–242.[CrossRef][Medline]
  22. Allen E. The estrous cycle in the mouse. Am J Anat 1922; 30:297–348.[CrossRef]
  23. Feder HH. Estrous cyclicity in mammals. In: Adler NT (ed.), Neuroendocrinology of Reproduction, Physiology and Behavior. New York: Plenum Press; 1981: 227–348.
  24. Jackson AL, Murphy LL. Role of the hypothalamic-pituitary-adrenal axis in the suppression of luteinizing hormone release by delta-9-tetrahydrocannabinol. Neuroendocrinology 1997; 65:446–452.[Medline]
  25. Luna LG. Manual of Histological Staining Methods of the Armed Forces Institute of Pathology. New York: McGraw-Hill; 1968.
  26. Pedersen RA, Peters H. Proposal for a classification of oocytes and follicles in the mouse ovary. J Reprod Fertil 1968; 83:555–557.
  27. Butcher RL, Kirkpatric-Keller D. Pattern of follicular growth during the four-day oestrus cycle in the rat. Biol Reprod 1984; 31:280–286.[Abstract]
  28. Fransen J, Verheyen A, Marsboom R. Morphological study of the corpus luteum in the rat. J Small Anim Pract 1993; 34:232–238.
  29. Steel RGD, Torrie JH. Principles and Procedures of Statistics: A Biometrical Approach, 2nd ed. New York: McGraw-Hill; 1980: 137–171.
  30. Shesely EG, Maeda N, Kim H-S, Desai KM, Krege KH, Laubach VE, Sherman PA, Sessa WC, Smithies O. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci USA 1996; 93:3531–3539.
  31. Hirshfield AN, Midgley AR Jr. Morphometric analysis of follicular development in the rat. Biol Reprod 1978; 19:597–605.[Abstract]
  32. Hesla JS, Preutthipan S, Maguire MP, Chang TSK, Wallach EE, Dharmarajan AM. Nitric oxide modulates human chorionic gonadotropin-induced ovulation in the rabbit. Fertil Steril 1997; 67:548–552.[CrossRef][Medline]
  33. Viscent SR, Kimura H. Histochemical mapping of nitric oxide synthase in the brain. Neuroscience 1992; 46:755–784.[CrossRef][Medline]
  34. Bredt DS, Hwang PM, Snyder SH. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 1990; 347:768–770.[CrossRef][Medline]
  35. Ceccatelli S, Hulting AL, Zhang X, Gustafsson L, Villar M, Hokfet T. Nitric oxide synthase in the rat anterior pituitary gland and the role of nitric oxide in regulation of luteinizing hormone secretion. Proc Natl Acad Sci USA 1993; 90:11292–11296.[Abstract/Free Full Text]
  36. Rettori V, Belova N, Dees WL, Nyberg CL, Gimeno M, McCann SM. Role of nitric oxide in the control of luteinizing hormone-releasing hormone release in vivo and in vitro. Proc Natl Acad Sci USA 1993; 90:10130–10134.[Abstract/Free Full Text]
  37. Bonavera JJ, Sahu A, Kalra SP. Evidence that nitric oxide may mediate the ovarian steroid-induced luteinizing hormone surge: involvement of excitatory amino acids. Endocrinology 1993; 133:2481–2487.[Abstract/Free Full Text]
  38. Moretto M, Lopez FJ, Negro-Vilar A. Nitric oxide regulates luteinizing hormone-releasing hormone secretion. Endocrinology 1993; 33:2399–2402.
  39. Chatterjee S, Collins TJ, Yallampalli C. Inhibition of nitric oxide facilitates LH release from rat pituitaries. Life Sci 1997; 61:45–50.[CrossRef][Medline]
  40. Monroe SE, Rebar RW, Gay VL, Midgley AR. Radioimmunoassay determination of luteinizing hormone during the estrous cycle of the rat. Endocrinology 1969; 85:720–724.[Abstract/Free Full Text]
  41. Piacsek BE, Schneider TC, Gay VL. Sequential study of luteinizing hormone (LH) and "progestin" secretion on the afternoon of proestrus in the rat. Endocrinology 1971; 89:39–45.[Abstract/Free Full Text]
  42. Nequin LG, Alvarez J, Schwartz NB. Steroid control of gonadotropin release. J Steroid Biochem 1975; 6:1007–1012.[CrossRef][Medline]
  43. Goodman RL. A quantitative analysis of the physiological role of estradiol and progesterone in the control of tonic and surge secretion of luteinizing hormone in the rat. Endocrinology 1978; 102:142–150.[Abstract/Free Full Text]
  44. Karla SP. Observations on facilitation of the preovulatory rise of LH by estrogens. Endocrinology 1975; 96:23–28.[Abstract/Free Full Text]
  45. Mahesh VB. The dynamic interaction between steroids and gonadotropins in the mammalian ovulatory cycle. Neurosci Biobehav Rev 1985; 9:245–260.[CrossRef][Medline]
  46. Michael SD. Plasma prolactin and progesterone during the estrous cycle in the mouse. Proc Soc Exp Biol Med 1976; 153:254–257.[Medline]
  47. Turgeon J. Estradiol-luteinizing hormone relationship during the proestrus gonadotropin surge. Endocrinology 1979; 105:731–736.[Abstract/Free Full Text]
  48. Snyder GD, Holmes RW, Batas JN, Van Voorhis BJ. Nitric oxide inhibits its aromatase activity: mechanisms of actions. J Steroid Biochem Mol Biol 1996; 58:63–69.[CrossRef][Medline]
  49. Bartke A, Steger RW, Hodges SL, Parkening TA, Collins TJ, Yun JS, Wagner TE. Infertility in transgenic female mice with hGH expression: evidence for luteal failure. J Exp Zool 1988; 248:121–124.[CrossRef][Medline]
  50. Ikeda A, Matsumoto Y, Chang KT, Nakano T, Matsuyama S, Yamanouchi K, Ohta A, Nishihara M, Tojo H, Sasaki F, Takahashi M. Different female reproductive phenotypes determined by human growth hormone (hGH) levels in hGH-transgenic rats. Biol Reprod 1997; 56:847–851.[Abstract]



This article has been cited by other articles:


Home page
ReproductionHome page
P. Pallares, R. A Garcia-Fernandez, L. M Criado, C. A Letelier, D. Esteban, J. M Fernandez-Toro, J. M Flores, and A. Gonzalez-Bulnes
Disruption of the endothelial nitric oxide synthase gene affects ovulation, fertilization and early embryo survival in a knockout mouse model
Reproduction, November 1, 2008; 136(5): 573 - 579.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Lapointe, M. Roy, I. St-Pierre, S. Kimmins, D. Gauvreau, L. A. MacLaren, and J.-F. Bilodeau
Hormonal and Spatial Regulation of Nitric Oxide Synthases (NOS) (Neuronal NOS, Inducible NOS, and Endothelial NOS) in the Oviducts
Endocrinology, December 1, 2006; 147(12): 5600 - 5610.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
G. B Silberstein, K. Van Horn, E. Hrabeta-Robinson, and J. Compton
Estrogen-triggered delays in mammary gland gene expression during the estrous cycle: evidence for a novel timing system.
J. Endocrinol., August 1, 2006; 190(2): 225 - 239.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Ray, X. Hou, H.-E. Zhou, H. Wang, and S. K. Das
Bip Is a Molecular Link between the Phase I and Phase II Estrogenic Responses in Uterus
Mol. Endocrinol., August 1, 2006; 20(8): 1825 - 1837.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
P Froment, F Gizard, D Defever, B Staels, J Dupont, and P Monget
Peroxisome proliferator-activated receptors in reproductive tissues: from gametogenesis to parturition.
J. Endocrinol., May 1, 2006; 189(2): 199 - 209.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
V. Sriraman, M. D. Rudd, S. M. Lohmann, S. M. Mulders, and J. S. Richards
Cyclic Guanosine 5'-Monophosphate-Dependent Protein Kinase II Is Induced by Luteinizing Hormone and Progesterone Receptor-Dependent Mechanisms in Granulosa Cells and Cumulus Oocyte Complexes of Ovulating Follicles
Mol. Endocrinol., February 1, 2006; 20(2): 348 - 361.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Q. Chen, T. Yano, H. Matsumi, Y. Osuga, N. Yano, J. Xu, O. Wada, K. Koga, T. Fujiwara, K. Kugu, et al.
Cross-Talk between Fas/Fas Ligand System and Nitric Oxide in the Pathway Subserving Granulosa Cell Apoptosis: A Possible Regulatory Mechanism for Ovarian Follicle Atresia
Endocrinology, February 1, 2005; 146(2): 808 - 815.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. C. Baccari, D. Bani, M. Bigazzi, and F. Calamai
Influence of Relaxin on the Neurally Induced Relaxant Responses of the Mouse Gastric Fundus
Biol Reprod, October 1, 2004; 71(4): 1325 - 1329.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
L. M. Mitchell, C.R. Kennedy, and G. M. Hartshorne
Pharmacological manipulation of nitric oxide levels in mouse follicle cultures demonstrates key role of extrafollicular control of ovulation
Hum. Reprod., August 1, 2004; 19(8): 1705 - 1712.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
F. Shi, R. L. Stewart Jr, E. Perez, J. Y.-H. Chen, and P. S. LaPolt
Cell-Specific Expression and Regulation of Soluble Guanylyl Cyclase {alpha}1 and {beta}1 Subunits in the Rat Ovary
Biol Reprod, June 1, 2004; 70(6): 1552 - 1561.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. C. Baccari, S. Nistri, S. Quattrone, M. Bigazzi, T. Bani Sacchi, F. Calamai, and D. Bani
Depression by Relaxin of Neurally Induced Contractile Responses in the Mouse Gastric Fundus
Biol Reprod, January 1, 2004; 70(1): 222 - 228.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
S. Tranguch, N. Steuerwald, and Y. M. Huet-Hudson
Nitric Oxide Synthase Production and Nitric Oxide Regulation of Preimplantation Embryo Development
Biol Reprod, May 1, 2003; 68(5): 1538 - 1544.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
Y. Nakamura, Y. Yamagata, N. Sugino, H. Takayama, and H. Kato
Nitric Oxide Inhibits Oocyte Meiotic Maturation
Biol Reprod, November 1, 2002; 67(5): 1588 - 1592.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
K. Mitsube, U. Zackrisson, and M. Brannstrom
Nitric oxide regulates ovarian blood flow in the rat during the periovulatory period
Hum. Reprod., October 1, 2002; 17(10): 2509 - 2516.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. Gyurko, S. Leupen, and P. L. Huang
Deletion of Exon 6 of the Neuronal Nitric Oxide Synthase Gene in Mice Results in Hypogonadism and Infertility
Endocrinology, July 1, 2002; 143(7): 2767 - 2774.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
C. M. Komar and T. E. Curry Jr
Localization and Expression of Messenger RNAs for the Peroxisome Proliferator-Activated Receptors in Ovarian Tissue from Naturally Cycling and Pseudopregnant Rats
Biol Reprod, May 1, 2002; 66(5): 1531 - 1539.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
C. M. Komar, O. Braissant, W. Wahli, and T. E. Curry Jr.
Expression and Localization of PPARs in the Rat Ovary During Follicular Development and the Periovulatory Period
Endocrinology, November 1, 2001; 142(11): 4831 - 4838.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
C. Tempfer, G. Unfried, R. Zeillinger, L. Hefler, F. Nagele, and J. C. Huber
Endothelial nitric oxide synthase gene polymorphism in women with idiopathic recurrent miscarriage
Hum. Reprod., August 1, 2001; 16(8): 1644 - 1647.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
L. A. Hefler, C. A. Reyes, W. E. O'Brien, and A. R. Gregg
Perinatal Development of Endothelial Nitric Oxide Synthase-Deficient Mice
Biol Reprod, February 1, 2001; 64(2): 666 - 673.
[Abstract] [Full Text]


Home page
Biol. Reprod.Home page
H. Matsumi, T. Yano, Y. Osuga, K. Kugu, X. Tang, J. P. Xu, N. Yano, Y. Kurashima, T. Ogura, O. Tsutsumi, et al.
Regulation of Nitric Oxide Synthase to Promote Cytostasis in Ovarian Follicular Development
Biol Reprod, July 1, 2000; 63(1): 141 - 146.
[Abstract] [Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jablonka-Shariff, A.
Right arrow Articles by Olson, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jablonka-Shariff, A.
Right arrow Articles by Olson, L. M.
Agricola
Right arrow Articles by Jablonka-Shariff, A.
Right arrow Articles by Olson, L. M.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS